Publications by authors named "Fabrizio Cavalca"

Claim this Profile
N
Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes.
Valentina Sangiorgio, Federica Mottadelli, Fabio Pagni, Fabrizio Cavalca, Giovanni Cazzaniga

Int J Lab Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea.
Francesca Palandri, Massimo Breccia, Elena M Elli, Roberto Latagliata, Giulia Benevolo, Fabrizio Cavalca

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study.
Francesca Palandri, Massimo Breccia, Erika Morsia, Elena M Elli, Giulia Benevolo, Fabrizio Cavalca

Leuk Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype.
Ivan Civettini, Arianna Zappaterra, Paola Corti, Amedeo Messina, Andrea Aroldi, Fabrizio Cavalca

Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: A new promising predictor of thrombotic events.
Alessia Ripamonti, Fabrizio Cavalca, Laura Montelisciani, Laura Antolini, Carlo Gambacorti-Passerini

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making.
Ivan Civettini, Arianna Zappaterra, Bianca Maria Granelli, Giovanni Rindone, Andrea Aroldi, Fabrizio Cavalca

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis.
Francesca Palandri, Giuseppe A Palumbo, Massimiliano Bonifacio, Elena M Elli, Mario Tiribelli, Fabrizio Cavalca

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial.
Beatrice Vergnano, Davide Signori, Annalisa Benini, Serena Calcinati, Francesca Bettini, Fabrizio Cavalca

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, Francesco Mannelli, Valerio De Stefano, Fabrizio Cavalca

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, Alessandra Iurlo, Marta Anna Sobas, Fabrizio Cavalca

Am J Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough infections in MPN-COVID vaccinated patients.
Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, Alessandra Iurlo, Valerio De Stefano, Fabrizio Cavalca

Blood Cancer J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706).
Elisa Bossi, Andrea Aroldi, Lorenza Maria Borin, Luisa Verga, Diletta Fontana, Fabrizio Cavalca

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis.
Daniele Cattaneo, Claudia Vener, Elena Maria Elli, Cristina Bucelli, Nicole Galli, Fabrizio Cavalca

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second versus first wave of COVID-19 in patients with MPN.
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Fabrizio Cavalca

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of recovered MPN patients with COVID-19.
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Fabrizio Cavalca

Blood Cancer J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.
Fabrizio Cavalca, Rossella Renso, Giovanni Paolo Maria Zambrotta, Carlo Gambacorti-Passerini, Elena Maria Elli

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Tiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Fabrizio Cavalca

Leukemia· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Fabrizio Cavalca

Blood Cancer J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
Nicola Stefano Fracchiolla, Mariarita Sciumè, Nicola Orofino, Francesca Guidotti, Anna Grancini, Fabrizio Cavalca

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis